Transvaginal sonographic and hysteroscopic findings in postmenopausal women receiving tamoxifen

Journal of the American Association of Gynecologic Laparoscopists

Volumn 4, Issue 3, 1997, Pages 331-339

  Marconi, Daniela ^a   Exacoustos, Caterina ^a,b   Cangi, Barbara ^a   Perroni, Antonella ^a   Zupi, Errico ^a   Valli, Edoardo ^a   Romanini, Carlo ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b Università degli Studi di Roma   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ARTICLE; BREAST CANCER; COLOR ULTRASOUND FLOWMETRY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTEROSCOPY; ITALY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; TRANSVAGINAL ECHOGRAPHY; VAGINA BLEEDING;

EID: 0030915027     PISSN: 10743804     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-3804(05)80224-5     Document Type: Article

References (71)

1. Sunderland MC, Osborne CK: Tamoxifen in premenopausal patients with metastatic breast cancer: A review. J Clin Oncol 9:1283-1297, 1991
2. Jordan VC: Molecular mechanisms of antiestrogen action in breast cancer. Breast Cancer Res Treat 31:41-52, 1994
3. Friedl A, Jordan VC: What do we know and what don't we know about tamoxifen in human uterus? Breast Cancer Res Treat 31:27-39, 1994
4. Quinn M, Allen E: Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ 311:1391-1395, 1995
5. Kedar RP, Bourne TH, Powles TJ, et al: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318-1321, 1994
6. Powles TJ, Jones AL, Ashley SE, et al: The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 31:73-82, 1994
7. Gotzinger P, Gnant M, Hochstoger E, et al: The potential impact of tamoxifen in breast cancer prevention. Onkologie 16:297-303, 1993
8. Neven P, Shepherd JH, Lowe DG: Tamoxifen and the gynaecologist. Br J Obstet Gynaecol 100:893-897, 1993
9. Powles TJ, Hickish T: Tamoxifen therapy and carcinogenic risk. J Natl Cancer Inst 87:1343-1345, 1995
10. Gottardis MM, Robinson SP, Satyaswaroop PG, et al: Contrasting actions of tamoxifen on endometrial and breast tumor in the athymic mouse. Cancer Res 48:812-815, 1988
11. Jordan CV: Tamoxifen and tumorigenicity: A predictable concern. J Natl Cancer Inst 87:623-626, 1995
12. Rutqvist LE, Johansson H, Signomklao T, et al: Adjuvant tamoxifen therapy for early stage breast cancer and secondary primary malignancies. J Natl Cancer Inst 87:645-651, 1995
13. Jordan VC: How safe is tamoxifen? BMJ 307:1371-1372, 1993
14. The Breast Cancers Trial Committee, Scottish Cancers Trial Office, (MRC): Adjuvant tamoxifen in the management of operable breast cancer: The Scottish trial. Lancet 2:171-175, 1987
15. Malfetano JH: Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients. Gynecol Oncol 39:82-83, 1990
16. Fonander T, Cedermark B, Mattsson A, et al: Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers. Lancet 1:117-119, 1989
17. Wolf DM, Jordan VC: Gynecologic complications associated with long-term adjuvant tamoxifen therapy for breast cancer. Gynecol Oncol 45:118-128; 1992
18. Cohen I, Rosen JD, Shapira J, et al: Endometrial changes in postmenopausal women treated with tamoxifen for breast cancer. Br J Obstet Gynaecol 100:567-570, 1993
19. Ugwumadu A: Endometrial changes and lesions in postmenopausal women treated with tamoxifen. Br J Obstet Gynaecol 100:704-705, 1993
20. Magriples U, Naftolin F, Schwartz PE, et al: High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients. J Clin Oncol 11:485-490, 1993
21. Deprest J, Neven P, Ide P: An unusual type of endometrial cancer, related to tamoxifen? Eur J Obstet Gynecol Reprod Biol 46:147-150, 1992
22. Seoud M, Johnson J, Weed JC: Gynecologic tumors in tamoxifen-treated women with breast cancer. Obstet Gynecol 82:165-169, 1993
23. Uziely B, Lewin A, Brufman G, et al: The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 26:101-105, 1993
24. Lahti E, Blanco G, Kauppila A, et al: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81:660-664, 1993
25. Neven P: Tamoxifen and endometrial lesions. Lancet 342:452, 1993
26. Ciatto S, Cecchini S, Bonardi R, et al: Ultrasonography surveillance of endometrium in breast cancer patients on adjuvant tamoxifen. Lancet 344:60, 1994
27. Cohen I, Rosen JD, Shapira J, et al: Endometrial changes with tamoxifen: Comparison between tamoxifen-treated and non-treated asymptomatic, postmenopausal breast cancer patients. Gynecol Oncol 52:185-190, 1994
28. Van Leeuwen FE, Benraadt J, Coebrgh JWW, et al: Risk of endometrial cancer after tamoxifen treatment of breast cancer. Lancet 343:448-452, 1994
29. Cohen I, Tepper R, Rosen JD, et al: Continuous tamoxifen treatment in asymptomatic, postmenopausal breast cancer patients does not cause aggravation of endometrial pathologies. Gynecol Oncol 55:138-143, 1994
30. Cook LS, Weiss NS, Schwartz SM, et al: Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers. J Natl Cancer Inst 87:1359-1364, 1995
31. Robinson DC, Bloss JD, Schiano MA: A retrospective study of tamoxifen and endometrial cancer in breast cancer patients. Gynecol Oncol 59:186-190, 1995
32. Le Bouedec G, Pingeon JM, Fondrinier E, et al: Surveillance gynecologique des traitements du cancer du sein par le tamoxifene. Rev Fr Gynecol Obstet 90:7-91, 1995
33. Neven P, Aleem FA, Predanic M: Endometrial changes in patients on tamoxifen. Lancet 346:1292-1293, 1995
34. Fabian CJ: Long-term tamoxifen treatment for breast cancer. J Natl Cancer Inst 87:1176-1177, 1995
35. Fisher B, Costantino JP, Redmond CK, et al: Endometrial cancer in tamoxifen-treated breast cancer patients: Findings from the national adjuvant breast and bowel project (NSAPB-14). J Natl Cancer Inst 86:527-580, 1994
36. Bourne TH: Evaluating the endometrium of postmenopausal women with transvaginal ultrasonography. Ultrasound Obstet Gynecol 6:75-80, 1995
37. Fleischer AC, Gordon AN, Entman SS, et al: Transvaginal scanning of the endometrium. J Clin Ultrasound 18:337-349, 1990
38. Goldstein SR, Nachtingal M, Snyder JR, et al: Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119-123, 1990
39. Wikland M, Grandberg S, Karlsson B: Assessment of the endometrium in the postmenopausal woman by vaginal sonography. Ultrasound Q 10:15-27, 1992
40. Osmers R: Transvaginal sonography in endometrial cancer. Ultrasound Obstet Gynecol 2:2-3, 1992
41. Dorum A, Kristensen GB, Langebrekke Sorness T, et al: Evaluation of endometrial thickness measured by endovaginal ultrasound in women with postmenopausal bleeding. Acta Obstet Gynecol Scand 72:116-119, 1993
42. Sheth S, Hamper UM, Kurman RJ: Thickened endometrium in the postmenopausal woman: Sonographic-pathologic correlation. Radiology 187:135-139, 1993
43. Kurjak A, Jurkovic D, Alfirevic Z, et al: Transvaginal color Doppler imaging. J Clin Ultrasound 18:227-234, 1990
44. Bourne T H, Campbell S, Steer CV, et al: Detection of endometrial cancer by transvaginal ultrasound with color flow imaging and blood flow analysis: A preliminary report. Gynecol Oncol 40:253-259, 1991
45. Kurjak A, Shalan H, Sosic A, et al: Endometrial carcinoma in postmenopausal women: Evaluation by transvaginal color Doppler ultrasonography. Am J Obstet Gynecol 169:1597-1603, 1993
46. Kupesic-Urek S, Shalan H, Kurjak A: Early detection of endometrial cancer by transvaginal color Doppler. Eur J Obstet Gynecol Reprod Biol 49:46-49, 1993
47. Carter J, Saltzman A, Hartenbach E, et al: Flow characteristics in benign and malignant tumors using transvaginal color flow Doppler. Obstet Gynecol 83:125-130, 1994
48. Loffer FD: Hysteroscopy with selective endometrial sampling compared with D&C for abnormal uterine bleeding: The value of negative hysteroscopic view. Obstet Gynecol 73:16-20, 1989
49. Badey A, Ash A, Nagele F, et al: Is it worth taking a biopsy of the normal looking endometrium? Gynaecol Endosc 5:225-229, 1996
50. Valle RF: Hysteroscopy. Curr Opin Obstet Gynecol 3:422-426, 1991
51. Gimpelson RJ: Office hysteroscopy. Clin Obstet Gynecol 35:270-281, 1992
52. Mencaglia L: Hysteroscopy and adenocarcinoma. Obstet Gynecol Clin North Am 22:573-579, 1995
53. Valli E, Zupi E, Marconi D, et al: A new score for endometrial lesions based on hysteroscopic parameters: Preliminary results. Gynaecol Endosc 3:185-188, 1994
54. Valli E, Zupi E, Solima E, et al: A new hysteroscopic classification and nomenclature for endometrial lesions. J Am Assoc Gynecol Laparosc 2:279-283, 1995
55. Zupi E, Valli E, Marconi D, et al: The use of topical anesthesia in diagnostic hysteroscopy and endometrial biopsy. Fertil Steril 63:414-416, 1995.
56. Mazur MT, Kurman RJ: Diagnosis of Endometrial Biopsies and Currettings. New York, Springer-Verlag, 1995, pp 102-103, 120-123, 146-159
57. De Muylder X, Neven P, De Somer M, et al: Endometrial lesions in patients undergoing tamoxifen therapy. Int J Gynecol Obstet 36:127-130, 1991
58. Neven P, De Muylder X, Van Belle Y, et al: Hysteroscopic follow-up during tamoxifen treatment. Eur J Obstet Gynecol Reprod Biol 35:235-238, 1990
59. Hulka CA, Hall DA: Endometrial abnormalities associated with tamoxifen therapy for breast cancer: Sonographic and pathologic correlation. AJR 160:809-812, 1993
60. Corley D, Rowe J, Curtis MT, et al: Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol 79:111-116, 1992
61. Goldstein SR: Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 170:447-451, 1994
62. Perrot N, Guyot B, Antoine M, et al: The effects of tamoxifen on the endometrium. Ultrasound Obstet Gynecol 4:83-84, 1994
63. Nuovo MA, Nuovo GJ, McCaffrey RM, et al: Endometrial polyps in postmenopausal patients receiving tamoxifen. Int J Gynecol Pathol 8:125-131, 1989
64. Exacoustos C, Zupi E, Cangi B, et al: Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: An ultrasound, color flow Doppler, hysteroscopic and histological study. Ultrasound Obstet Gynecol 6:435-442, 1995
65. Achiron R, Grisaru D, Golan-Porat N, et al: Tamoxifen and the uterus: An old drug tested by new modalities. Ultrasound Obstet Gynecol 7:374-378, 1996
66. Tepper R, Cohen I, Altaras M, et al: Doppler flow evaluation of pathologic endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen. J Clin Ultrasound 13:635-640, 1995
67. Achiron R, Lipitz S, Sivan E, et al: Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen-treated women with breast cancer: A transvaginal Doppler study. Ultrasound Obstet Gynecol 6:116-120, 1995
68. Uzan S, Perrot N, Uzan M: Tamoxifen: Vaginosonography and color Doppler assessment of the uterus. Ultrasound Obstet Gynecol 3:306, 1992
69. Bourne T, Hillard TC, Whitehead MI, et al: Oestrogens, arterial status, and postmenopausal women. Lancet 335:1470-1471, 1990
70. Pirhonen JP, Vuento MH, Makinen JI, et al: Long-term effects of hormone replacement therapy on the uterus and on uterine circulation. Am J Obstet Gynecol 168:620-623, 1993
71. Achiron R, Lipitz S, Frenkel Y, et al: Endometrial blood flow response to estrogen replacement therapy and tamoxifen in asymptomatic, postmenopausal women: A transvaginal Doppler study. Ultrasound Obstet Gynecol 5:411-414, 1995